Publication: Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction.
dc.contributor.author | Morales-Ponce, Francisco J | |
dc.contributor.author | González-Pérez, Pablo | |
dc.contributor.author | Blasco-Turrión, Sara | |
dc.contributor.author | Sánchez-Brotons, Juan Antonio | |
dc.contributor.author | Collado-Moreno, Carmen | |
dc.contributor.author | Martínez-Romero, Pedro | |
dc.contributor.author | Martínez-Morentín, Eduardo | |
dc.contributor.author | Caro-Mateo, Pilar | |
dc.date.accessioned | 2023-02-09T10:39:37Z | |
dc.date.available | 2023-02-09T10:39:37Z | |
dc.date.issued | 2021-01-13 | |
dc.identifier.doi | 10.5603/CJ.a2021.0002 | |
dc.identifier.essn | 1898-018X | |
dc.identifier.pmc | PMC8105071 | |
dc.identifier.pmid | 33438179 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105071/pdf | |
dc.identifier.unpaywallURL | https://journals.viamedica.pl/cardiology_journal/article/download/CJ.a2021.0002/52966 | |
dc.identifier.uri | http://hdl.handle.net/10668/16966 | |
dc.issue.number | 1 | |
dc.journal.title | Cardiology journal | |
dc.journal.titleabbreviation | Cardiol J | |
dc.language.iso | en | |
dc.organization | Hospital Universitario de Puerto Real | |
dc.page.number | 176-178 | |
dc.pubmedtype | Journal Article | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject.mesh | Abciximab | |
dc.subject.mesh | Fibrinolytic Agents | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Immunoglobulin Fab Fragments | |
dc.subject.mesh | Myocardial Infarction | |
dc.subject.mesh | Platelet Aggregation Inhibitors | |
dc.subject.mesh | Tenecteplase | |
dc.subject.mesh | Treatment Outcome | |
dc.subject.mesh | Ventricular Function | |
dc.title | Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 28 | |
dspace.entity.type | Publication |